Featured news from NHIVNA
HIV-related news from NAM
Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection
Liz Highleyman, 2015-07-20 12:20:00
The development of effective new interferon-free treatment makes it possible to cure more than 90% of people with chronic hepatitis C, including most people with HIV and hepatitis C virus (HCV) co-infection, researchers said at the Second International HIV/Viral Hepatitis Co-infection Meeting, preceding the Eighth International AIDS Society Conference (IAS 2015) taking place this week in Vancouver, Canada. Looking at hepatitis B, antiviral therapy can effectively suppress the virus long-term, but most people are still not cured.
Expanding access to expensive hepatitis C treatments has become a key issue in the field as the challenge of developing highly effective and well-tolerated therapy has been largely solved. But taking a step back, a large proportion of people with hepatitis B or C around the world have not been diagnosed, and countries often do not have a good understanding of the extent of their viral hepatitis public health problems.
Source:1
